AI-Enhanced Chronic Obstructive Sleep Apnea Coaches | A $1.92 Billion Global Market in 2026

The market is rapidly growing due to rising sleep disorder prevalence, increasing demand for remote monitoring, and integration with connected devices. Opportunities lie in personalized digital therapeutics and proactive disease management. April 27, 2026 06:55 ET | Source: Research and Markets Research and Markets

Dublin, April 27, 2026 (GLOBE NEWSWIRE) -- The "AI-Enhanced Chronic Obstructive Sleep Apnea Coach Market Report 2026" has been added to ResearchAndMarkets.com's offering. The AI-enhanced chronic obstructive sleep apnea (OSA) coach market is experiencing significant growth. From a valuation of $1.61 billion in 2025, it's projected to swell to $1.92 billion by 2026, advancing at an impressive compound annual growth rate (CAGR) of 19.5%. The surge in market size can be attributed to the rising incidence of sleep apnea and respiratory issues, increased awareness regarding sleep health management, the proliferation of home-based monitoring solutions, and the digital health platform expansion. Looking forward, the market is anticipated to soar to $3.88 billion by 2030, driven by a CAGR of 19.2%. This expected growth is fueled by the rising adoption of AI tools for chronic disease management, increased demand for remote patient monitoring, the expansion of personalized digital therapeutics, and growing integration with connected medical devices. Trends that will likely dominate include continuous sleep monitoring, AI-driven therapy adherence coaching, and the proliferation of personalized sleep health platforms. The increase in sleep disorders, exacerbated by modern stressors such as demanding work environments and screen time, is set to propel the growth of this market. AI-enhanced sleep apnea coaches offer comprehensive management of sleep disorders through real-time monitoring and data-driven insights, supporting early detection of complications and improving sleep quality. A recent UK report highlighted an increase in sleep disturbances among youth, with 64.9% experiencing sleep issues frequently—an uptick from 2022—which underscores the burgeoning demand for AI-driven solutions. Industry leaders like ResMed Inc. are innovating with products such as the AirCurve 11 series, a bilevel device providing dual‑pressure support for effective sleep apnea therapy. Such advances offer features like secure data transfer, automatic software updates, and robust patient engagement tools, improving both patient experience and therapy compliance. In another strategic expansion, Aeroflow Sleep partnered with EnsoData to utilize predictive AI models for proactive patient management of sleep apnea in the U.S. This initiative aims to improve patient adherence and optimize therapeutic outcomes using AI-generated insights. Prominent players in this market include Koninklijke Philips N.V., Sleep Number Corporation, Nihon Kohden Corporation, and many others. North America led market contributions in 2025, while the Asia‑Pacific region is expected to see the fastest growth moving forward. The report provides comprehensive statistics and analysis, offering valuable insights for stakeholders to capitalize on growth opportunities. Overall, the AI-enhanced OSA coach market is positioned for robust expansion, aided by technological advances and heightened global awareness of sleep health.

Markets Covered: Components: Software, Hardware, Services; Deployment Modes: Cloud-Based, On-Premises; Applications: Home Care, Sleep Clinics, Hospitals, Research Institutes; End-Users: Patients, Healthcare Providers, Sleep Specialists

Subsegments: Software: Cloud Platforms, Mobile Apps, Analytics Tools; Hardware: Sleep Trackers, Monitoring Devices; Services: Patient Monitoring, Sleep Coaching, Technical Support

Key Companies Mentioned: Koninklijke Philips N.V., ResMed Inc., Sleep Number Corporation, Nihon Kohden Corporation, Fisher & Paykel Healthcare, Verily Life Sciences, and more. Countries and Regions: Notable presence in Asia‑Pacific, Europe, North and South America, with detailed analyses of specific countries like China, Germany, Japan, and the USA. Time Series: Five years historical data and ten years forecast. Key Attributes: No. of Pages 250; Forecast Period 2026‑2030; Estimated Market Value (USD) in 2026 $1.92 Billion; Forecasted Market Value (USD) by 2030 $3.88 Billion; Compound Annual Growth Rate 19.2%; Regions Covered Global

The companies featured in this AI-Enhanced Chronic Obstructive Sleep Apnea Coach market report include: Koninklijke Philips N.V., ResMed Inc., Sleep Number Corporation, Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Verily Life Sciences LLC, Natus Medical Incorporated, SomnoMed Limited, BMC Medical Co., Ltd., Eight Sleep, Inc., Sleepiz AG, Sleep.ai B.V. (SleepScore Labs), EnsoData, Inc., SovaSage, Inc., Somnics Inc., Sleep Doctor, LLC, Sommetrics, Inc., Nyxoah S.A., Neru Health Inc., Apnea-Tech Limited.

About ResearchAndMarkets.com: ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

AI-Enhanced Chronic Obstructive Sleep Apnea Coaches | A $1.92 Billion Global Market in 2026

ResearchAndMarkets.com added the AI-Enhanced Chronic Obstructive Sleep Apnea Coach Market Report 2026 to its portfolio, projecting the market to grow from $1.61 billion in 2025 to $1.92 billion in 2026 and $3.88 billion by 2030. ResMed Inc. is developing the AirCurve 11 bilevel device, while Aeroflow Sleep partnered with EnsoData to apply predictive AI for patient management in the U.S. The market growth is driven by rising sleep apnea incidence, remote monitoring demand, and digital health platform expansion, with key trends in continuous monitoring, AI‑driven coaching, and personalized platforms.